Home/Pipeline/Next-Gen Hardware/Software

Next-Gen Hardware/Software

Diabetes Management

R&DDevelopmentN/A

Key Facts

Indication

Diabetes Management

Phase

R&D

Status

Development

Company

Insulet

About Insulet

Insulet Corporation is a mission-driven leader in tubeless insulin pump technology, dedicated to simplifying diabetes management and improving quality of life. Its core achievement is the Omnipod 5 Automated Insulin Delivery System, the #1 prescribed insulin pump, which has demonstrated significant clinical benefits in both type 1 and type 2 diabetes. The company's strategy leverages a disruptive pharmacy benefit distribution model to build direct patient relationships and drive adoption, supported by innovative marketing and a pipeline focused on expanding indications and platform integration.

View full company profile

Therapeutic Areas

Type 1 Diabetes Type 2 Diabetes (Insulin-requiring)

Other Diabetes Management Drugs

Drug	Company	Phase	Status
ALRT Diabetes Solution	ALR Technologies	Approved/Commercial	Active
Continuous Glucose Monitor	Allez Health	Approved	Active
Next-Gen Sensor & Algorithm Development	Medtrum France	Development	Active
Regulatory Expansion (e.g., FDA Submission)	Medtrum France	Regulatory	Active
CONTOUR BGM Portfolio Development	Ascensia Diabetes Care	Commercial	Active
Next-Generation CGM Integrations (e.g., Dexcom G7)	Tandem Diabetes	Integration/Regulatory	Active
International Market Expansion	Tandem Diabetes	Commercial	Active
CGM Ecosystem Integration	Insulet	Development/Regulatory	Active